AMLX stock forecast models from leading firms factor in expansion opportunities across global markets, with patient population estimates strengthening revenue projections. With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Amylyx Pharmaceuticals going out to 2026, and you can see them free on our platform here. To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. AMLX stock forecast has caught momentum from broader biotech ETF gains, with correlation analysis showing strong alignment. Price action near $20 could be the pivot for further rally attempts.
